Pfizer, Inc. (NYSE: PFE) reports top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE